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Background: The presence and extent of late gadolinium enhancement (LGE) has been associated with adverse
events in patients with hypertrophic cardiomyopathy (HCM). Signal intensity (SI) threshold techniques are routinely
employed for quantification; Full-Width at Half-Maximum (FWHM) techniques are suggested to provide greater
reproducibility than Signal Threshold versus Reference Mean (STRM) techniques, however the accuracy of these
approaches versus the manual assignment of optimal SI thresholds has not been studied. In this study, we
compared all known semi-automated LGE quantification techniques for accuracy and reproducibility among
patients with HCM.
Methods: Seventy-six HCM patients (51 male, age 54 ± 13 years) were studied. Total LGE volume was quantified
using 7 semi-automated techniques and compared to expert manual adjustment of the SI threshold to achieve
optimal segmentation. Techniques tested included STRM based thresholds of >2, 3, 4, 5 and 6 SD above mean SI of
reference myocardium, the FWHM technique, and the Otsu-auto-threshold (OAT) technique. The SI threshold
chosen by each technique was recorded for all slices. Bland-Altman analysis and intra-class correlation coefficients
(ICC) were reported for each semi-automated technique versus expert, manually adjusted LGE segmentation.
Intra- and inter-observer reproducibility assessments were also performed.
Results: Fifty-two of 76 (68%) patients showed LGE on a total of 202 slices. For accuracy, the STRM >3SD technique
showed the greatest agreement with manual segmentation (ICC = 0.97, mean difference and 95% limits of
agreement = 1.6 ± 10.7 g) while STRM >6SD, >5SD, 4SD and FWHM techniques systematically underestimated total
LGE volume. Slice based analysis of selected SI thresholds similarly showed the STRM >3SD threshold to most
closely approximate manually adjusted SI thresholds (ICC = 0.88). For reproducibility, the intra- and inter-observer
reproducibility of the >3SD threshold demonstrated an acceptable mean difference and 95% limits of agreement
of −0.5 ± 6.8 g and −0.9 ± 5.6 g, respectively.
Conclusions: FWHM segmentation provides superior reproducibility, however systematically underestimates total
LGE volume compared to manual segmentation in patients with HCM. The STRM >3SD technique provides the
greatest accuracy while retaining acceptable reproducibility and may therefore be a preferred approach for LGE
quantification in this population.
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Late gadolinium enhanced (LGE) cardiovascular magnetic
resonance (CMR) has the capacity to identify regional
accumulation of myocardial fibrosis in patients with
hypertrophic cardiomyopathy (HCM) [1-3]. This imaging
biomarker is identified in approximately two-thirds of pa-
tients with HCM and has been associated with adverse
outcomes [4,5]. However, given the high prevalence of this
finding when reported as a binary variable, accurate and
reproducible methodologies aimed at LGE burden quanti-
fication are required to more adequately estimate risk
among this population.
In contrast to ischemic injury, the fibrosis associated
with HCM is typically patchy and non-uniform, posing a
substantial challenge for manual segmentation. The vis-
ual application of a circumferential boundary is therefore
an inappropriate reference standard in this population,
particularly when being used to validate voxel-based
threshold techniques. Despite this, studies to date have
largely used manual planimetry as a reference when test-
ing semi-automated LGE segmentation. Such techniques
described to date include; i) Signal Threshold versus
Reference Mean (STRM) [1,4,6], ii) Full Width at Half
Maximum (FWHM) [7], and the Otsu Auto Threshold
(OAT) techniques [8]. The most notable comparative
study inclusive of patients with HCM by Flett et al. in-
cluded 20 patients with previously established diagnosis.
In this study, they reported that the FWHM technique re-
sulted in higher reproducibility metrics than for STRM
[9]. However, the accuracy of these techniques to replicate
an expert-based segmentation of LGE was not tested.
While other studies have attempted to determine the
accuracy of various STRM-based signal intensity (SI)
thresholds against a visual standard [6,10], manual LGE
planimetry is most commonly considered the reference
standard.
In this study we systematically investigated the accur-
acy and reproducibility of all known semi-automated
threshold-based LGE quantification techniques within a
large cohort of patients with confirmed HCM. We
employed a novel gold standard that represented signal
enhancement by expert visual adjustment of a signal in-
tensity threshold for each analyzed image. Based upon
our findings we provide recommendations for the opti-
mal selection of signal threshold techniques in reporting
total LGE among patients with HCM.
Methods
Patients
Patients were identified from a prospectively enrolled clin-
ical registry of HCM patients undergoing CMR between
March 2008 and May 2011 at the Cardiovascular MRI
Clinical Research (CMCR) Center at Western University,
Canada. Inclusion criteria for this study were adult patients(age ≥18) with echocardiographically diagnosed HCM, de-
fined according to AHA consensus guidelines, including
the presence of a hypertrophied (≥15 mm or ≥ 13 mm if a
1st degree relative with HCM) and non dilated left ven-
tricle in the absence of another cardiac or systemic disease
capable of producing this magnitude of hypertrophy [11].
Eighteen patients were excluded from analysis due to prior
surgical myomectomy or alcohol septal ablation. All
patients provided written informed consent and the
study protocol was approved by the Western University
Research Ethics Board.
CMR protocol
All CMR studies were performed on a clinical 3-T MRI
system (TRIO or Verio, Siemens Healthcare, Erlangen,
Germany) with a 32 channel cardiac coil using ECG gat-
ing. The imaging protocol involved short axis cine imaging
and LGE imaging. LGE imaging was performed using in-
version recovery gradient echo sequence 10 minutes after
the administration of Gadolinium contrast (Magnevist® or
Gadovist®, Bayer Inc, Toronto, Ontario, Canada) at a dose
of 0.2 mmol/kg. Typical imaging parameters for LGE
were: slice thickness 8 mm, gap 2 mm, TE 1.93 ms, flip
angle 20 degrees, matrix 256 × 205, TI individually deter-
mined to minimize the SI of normal myocardium range
200 to 400 ms.
Image analysis
All images were anonymized and analyzed in random
order. Cine images were blindly analyzed using certified
software (cvi42, Circle CVI, Calgary, Alberta, Canada) for
determination of LV volume, mass and ejection fraction
(EF). Papillary muscle was included as part of myocar-
dium. Maximum wall thickness was measured from the
short axis views.
LGE images were analyzed by an observer with 7 years
of experience in CMR (YM) using the same software
(cvi42, Circle CVI.). Magnitude reconstruction images were
used for image analysis to maximize clinical generalizability.
These were first evaluated for acceptability based upon an
appropriate adjustment of the inversion time, and ab-
sence of significant motion artifact. Seven patients were
excluded from the study due to unacceptable image
quality. For each short axis slice, the endocardial and
epidcardial boundaries were manually traced with care-
ful attention to avoid visually apparent artifacts or blood
pool. These same boundary contours were used for the
testing of all LGE quantification techniques to eliminate
the influence of contour tracing on threshold-based
LGE quantification. Total LGE volume was then quanti-
fied using 7 semi-automated techniques and compared
to an expert manual adjustment of the signal intensity
threshold, as shown in Figure 1. Techniques tested in-
cluded STRM-based thresholds of >2, >3, >4 > 5 and >6
Figure 1 Example of the expert Late Gadolinium Enhancement (LGE) segmentation procedure using a manual adjustment of the signal
intensity (SI) threshold for each LGE image. A manual SI threshold (circled) was adjusted using a slide bar until visually identified LGE was
segmented in accordance to expert opinion. Panel A shows a raw LGE image prior to application of segmentation. Panel B shows over-representation of
LGE at a low SI threshold of 11. Panel C shows “optimal segmentation” at a threshold of 36. Panel D shows under-representation of LGE at a higher
threshold of 78. The signal threshold of 36 (arrow) was applied for this image and the corresponding LGE area employed as a reference standard for
semi-automated technique comparison.
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FWHM technique, and the Otsu auto-threshold (OAT)
technique (Figure 2). For STRM-based assessments,
the reference myocardium was defined for each slice as
the largest contiguous area of myocardium with no
visually apparent LGE or artifact. For FWHM-based
assessments, the reference region was defined for each
slice as an area inclusive of the maximum signal intensity
of visually apparent LGE. The resulting SI threshold ap-
plied to define LGE for each technique was recorded.
Total LGE was determined on a per-patient basis for each
semi-automated technique as the sum of LGE area for
each slice multiplied by the slice thickness.
The gold standard of manual threshold assignment
was performed for each slice as follows; the SI threshold
for definition of LGE was set to zero (100% enhancement)
and then manually increased until the segmented signal
visually matched the visually identified LGE on each slice
(Figure 1). The manual signal threshold employed for each
slice was recorded.
Inter-observer and intra-observer reproducibility testing
was performed by two blinded investigators (YM and JW).
This was accomplished by repeating measurements inrandom order for 15 randomly selected patients. For
this analysis the same endocardial and epicardial contours
were used, again to focus reproducibility testing on the
threshold techniques themselves, inclusive of the ap-
plication of reference regions.Statistical analysis
All values were expressed as mean ± SD. Bland Altman
analysis and intraclass correlation coefficients (ICC)
were reported for each semi-automated technique versus
expert, manually adjusted segmentation. Intra and inter-
observer reproducibility assessments were similarly per-
formed using Bland Altman analysis and ICC. All analyses
were conducted using SPSS for Macintosh, version 19.0
(SPSS, Inc., Chicago, Illinois).Results
A total of 83 registry patients were available for image
analysis. Of these, seven were excluded due to suboptimal
image quality related to motion artifact or sub-optimal
adjustment of the time from inversion (TI time). This
resulted in 76 patients with HCM included in the study,
Figure 2 Comparison of; A) Raw LGE image, B) Expert manual segmentation, C) Signal Threshold versus Reference Mean (STRM)
threshold of ≥5SD, D), Full Width at Half Maximum (FWHM), and the E) Otsu auto-threshold (OAT) methods applied to the same
imaging slice. Reference tissue regions of interest (ROI) for remote myocardium (STRM method) and maximal signal enhancement (FWHM method)
are shown in blue and pink, respectively.
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All other patient characteristics are shown in Table 1.
Fifty-two patients (68%) were scored as having clear
visual evidence of LGE, this finding being identified on a
total of 202 out of 742 (27%) available image slices. Manual
expert segmentation using slice-based signal threshold
assignment resulted in a mean Total LGE burden
among the study population of 18.2 ± 20.4 g.
Accuracy of semi-automated LGE quantification techniques
Bland-Altman plots for the semi-automated signal threshold
techniques versus expert segmentation are shown in Figure 3.
Overall, the STRM >3SD technique showed the highest
agreement with manual segmentation with an ICC of 0.97
(mean difference and 95% limits of agreement: 1.6 ± 10.7 g).
The mean difference of total LGE burden obtained for each
of the 7 semi-automated techniques versus the manually
adjusted reference standard are shown in Figure 4. The
STRM >6SD, >5SD, >4SD and FWHM techniques were
found to systematically underestimate total LGE burden, as
shown in Figures 4 and 5. Conversely, the STRM >2SD and
OAT techniques were found to overestimate total LGE
burden in comparison to the gold standard.
Using slice-based analysis, the SI threshold applied by
each technique was compared to that obtained by manual
expert threshold adjustment. This analysis similarly identi-
fied the STRM >3SD threshold to most closely approximate
the manually adjusted SI threshold with an ICC of 0.88
(mean difference and 95% limits of agreement = 2.5 ± 16.8).
Reproducibility of semi-automated LGE quantification
techniques
Bland-Altman plots were performed for the assessment
of both inter- and intra-observer variability for semi-automated segmentation techniques and for manual ex-
pert segmentation. These analyses are shown in Figures 6
and 7.
Total LGE assessment by manual signal threshold
adjustment was found to be highly reproducible with a
mean difference and 95% limits of agreement between
observers of −1.3 ± 6.5 g, and 0.3 ± 7.8 g within the same
observer. Of the semi-automated techniques, the FWHM
method showed the highest intra- and inter-observer
reproducibility with a mean difference and 95% limits of
agreement between observers of 0.3 ± 2.2 g, and −0.1 ±
0.5 g within the same observer. Corresponding reprodu-
cibility values for STRM-based thresholds were found to
improve with increasing SI thresholds (Figures 6 and 7).
For example, for the intra-observer values for >2SD
and >6SD thresholds were −0.3 ± 7.5 g and −0.2 ± 4.5 g
while the inter-observer values were −0.7 ± 9.0 g and −0.6 ±
4.5 g, respectively.
The STRM >3SD threshold, identified among the tech-
niques as optimal with respect to precision, demonstrated
acceptable inter- and intra-observer ICC values of 0.992
and 0.995. The corresponding mean difference and 95%
limits of agreement were −0.5 ± 6.8 g and −0.9 ± 5.6 g,
respectively.Discussion
This is the largest analysis performed to date comparing
both the accuracy and reproducibility of semi-automated
SI threshold-based LGE quantification. In this study we
focused solely on patients with HCM, a cohort recog-
nized to pose challenge for LGE characterization due to
a patchy and non-uniform distribution. Uniquely, the
reference standard used in this analysis provided a more
Table 1 Patient characteristics (N = 76)
Age (years) 54 ± 13
Male, n (%) 51 (67)
Height (m) 1.7 ± 0.1
Weight (kg) 85.5 ± 18.5
BMI (kg/m2) 28.6 ± 5.3
Systolic BP (mmHg) 132 ± 18
Diastolic BP (mmHg) 77 ± 11
Heart Rate 65 ± 11
NYHA heart failure class, n (%)
Class I 48 (63)
Class II 17 (22)
Class III 9 (12)
Class IV 2 (3)
LVOT resting obstruction ≥ 30 mmHg by TTE, n (%) 18 (24)
CMR findings
LVEDVI (ml/m2) 60.1 ± 12.7
LVESVI (ml/m2) 16.2 ± 9.1
LVSVI (ml/m2) 43.9 ± 10.5
LV ejection fraction (%) 74 ± 12
Indexed LV mass (g/m2) 89 ± 27
LV maximal wall thickness (mm) 19 ± 6
LGE positive, n (%) 52 (68)
LGE mass (g) 18 ± 20
LGE mass (% of the LV mass) 11 ± 12
Values are presented as n (%) or mean ± SD. LV mass was indexed to body
surface area. NYHA class was determined by patients’ symptoms interviewed
at the time of Cardiovascular MRI. LGE mass values were by manual expert
segmentation using slice-based signal threshold assignment. BMI = Body Mass
Index; BP = Blood Pressure; NYHA = New York Heart Association; LV = Left
Ventricular; LVOT = Left Ventricular Outflow Tract; TTE = Transthoracic
echocardiogram; EDVI = Endo Diastolic Volume Indexed by body surface area;
ESVI = Endo Systolic Volume Indexed by body surface area; SVI = Stroke
Volume Indexed by body surface area; LGE = Late Gadolinium Enhancement.
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to the convention of manual planimetry.
The potential importance of LGE quantification in
patients with HCM has been highlighted by a number of
recent studies [4,5,12-16], each emphasizing a role for the
identification of patients at elevated risk of future cardio-
vascular events. Despite this, only limited data is available
regarding the accuracy of LGE quantification in this popu-
lation [6,9]. Specifically, in contrast to ischemia-mediated
injury, the distribution of collagen deposits in HCM ap-
pears highly variable in both density and distribution,
ranging from diffusely dispersed patches of collagen fibers
to dense and irregular islands of mature scar [1,17,18]. As
such, the manual application of a linear boundary to
quantify this phenomenon appears to be an inappropriate
gold standard. In the current study we attempted to miti-
gate this limitation by employing a manually-adjustedsignal threshold, a technique most congruent with the
threshold-based segmentation techniques being tested.
This provided a more appropriate expert-adjudicated
reference standard for the assessment of accuracy.
When compared to expert opinion, our results iden-
tified the STRM > 3SD technique to provide the closest
estimate of LGE burden among the population. STRM-
based thresholds below this cut-off (i.e.: >2SD) system-
atically over-estimated LGE burden compared to the
reference standard, while thresholds above this cut-off
(i.e.: >4SD, >5SD and >6SD) systematically under-estimated
LGE burden. The FWHM approach was shown to
under-estimate LGE burden, as illustrated in Figure 4,
while the OAT method systematically over-estimated
LGE burden. With respect to reproducibility we identi-
fied, similar to the report by Flett et al., that the FWHM
method provides superior reproducibility than STRM-
based methods [9].
Based upon our findings it appears that no “ideal” seg-
mentation technique currently exists for the quantification
of LGE among patients with HCM. And, depending upon
a preference towards accuracy or reproducibility, an
informed decision must be made to best answer the ques-
tion posed. However, when weighing the relative perform-
ance metrics of each technique, we conclude that the
STRM> 3SD technique may provide the most optimal re-
sult for general use with accuracy that best represents the
LGE burden identified by expert visual adjudication and
provides sufficiently robust reproducibility. While the
FWHM method remains attractive for reproducibility it
must be used in recognition of a significant under-
estimation of total LGE burden. The OAT method cannot
be recommended for use in this population.
LGE has been shown to be a predictor of worse out-
comes in HCM, inclusive of worse LV systolic dysfunction
[12], ventricular arrhythmias [5,13,14], sudden cardiac
death [13] and both all cause and cardiac mortality [4].
However, a particular challenge for its use for risk stratifi-
cation in this population is a high prevalence of LGE when
described as a binary finding; as high as 78% among those
with genetically confirmed disease with LVH [19]. As
such, attention towards quantification of LGE burden has
emerged, and this is reliant upon provision of both accur-
acy and reproducibility. While the lack of any ideal ap-
proach has led to appropriate exploration for alternate
techniques of fibrosis quantification through T1 mapping
[20,21], and extra cellular volume (ECV) fraction estima-
tion [19,22], it is anticipated that conventional LGE im-
aging will remain an important diagnostic and prognostic
tool in clinical practice for the foreseeable future. As such,
the standardization of LGE reporting in this population is
required.
Several recent studies have reported on the value of
volume-based quantification rather than dichotomous
Figure 3 Bland-Altman plots between each semi-automated technique and manual expert segmentation. The Signal Threshold versus
Reference Mean (STRM) >3SD technique showed greatest agreement with manual segmentation.
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LGE has been shown to be related to larger LV mass
[23] and reduced systolic function [12,23] in this popula-
tion. In a study of 217 HCM patients, the extent of LGE
was associated with risk of heart failure admissions, de-
terioration to New York Heart Association functional
class III or IV, or heart failure-related death over a mean
of 3.1 years [14]. Another study assessed progression of
LGE between 2 CMR examinations (mean interval ofFigure 4 Mean difference in Late Gadolinium Enhancement (LGE)
volume (g) and % difference (%) between each semi-automated
technique and expert segmentation by manual Signal Intensity
(SI) threshold adjustment technique. The Signal Threshold versus
Reference Mean (STRM) >3SD technique showed the greatest
agreement with manual segmentation while STRM >6SD, >5SD,
>4SD and full width at half maximum (FWHM) techniques
systematically underestimated total enhanced volume.719 days among 55 HCM patients) where a greater
interval increases in LGE was associated with worsening
of NYHA class [24]. Ismail et al. recently published a
study of 711 HCM patients diagnosed by standard clin-
ical criteria and followed them for a median of 3.5 years
[15]. Thirty-two patients reached the primary endpoint
of sudden cardiac death (SCD) or aborted SCD. The
extent of LGE quantified using the FWHM method was
a predictor of the primary endpoint by univariable ana-
lysis (HR per 5% LGE 1.24). However, this failed to re-
main predictive by multivariable analysis. The second
study, published by Chan et al., included 1293 HCM pa-
tients defined by CMR findings and followed for a me-
dian of 3.3 years [16]. Thirty-seven patients experienced
the primary outcomes of SCD or appropriate defibrilla-
tor therapy. The extent of LGE was quantified by a man-
ual adjustment of gray scale threshold (similar to that
used as the reference standard in the current study).
Using this approach, %LGE was a significant predictor
of the primary outcome in both univariate and multi-
variate analysis, the latter inclusive of relevant conven-
tional risk factors (adjusted HR of 1.46/10% increase in
LGE). A LGE burden ≥15% was associated with a HR of
2.14 and an estimated 5-year event rate of 6.3%. Whether
differences in LGE quantification methodology are adequate
to explain differences in predictive utility between the
Chan et al., and Ismail et al. studies remains uncertain.
However, such differences highlight a need to adopt a
common, standardized approach to LGE quantification.
Appropriate debate exists, and will continue to exist,
regarding optimal metrics of LGE quantification for the
Figure 5 Patient example of raw Late Gadolinium Enhanced (LGE) image (Panel A), manual expert segmentation (Panel B) versus full
width at half maximum (FWHM) -based segmentation (Panel C) and the Signal Threshold versus Reference Mean (STRM) -based
segmentation at >3SD (Panel D), >4SD (Panel E) and >5SD thresholds (Panel F). A significant under-estimation of visually identifiable LGE is
evident using the FWHM method.
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horts. Whether a single LGE threshold is optimal to pre-
dict arrhythmic events, or whether intermediate LGE
signal (ie: “border-zone”) is more discriminative among
patients with ischemic cardiomyopathy remains uncer-
tain [25-27]. This same debate could extend to the HCM
population, a recent study by Appelbaum et al. similarly
suggesting LGE signal between the range of 4SD and
6SD providing higher predictive value for non sustained
ventricular arrhythmia [28]. Irrespective, we must firstFigure 6 Bland-Altman plots of inter-observer variability for semi-autacknowledge fundamental strengths and weaknesses of
each segmentation technique, and only then select that
which is best suited to answer the question being posed.
Study limitations
This study was designed to assess the accuracy and
reproducibility of LGE quantification in patients with
echocardiographically confirmed HCM at a single academic
institution. Therefore, generalization of our findings beyond
this referral population cannot be recommended.omated techniques and manual segmentation.
Figure 7 Bland-Altman plots of intra-observer variability for semi-automated techniques and manual segmentation.
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ard was chosen as the best possible solution, it remains
imperfect in that subjectivity is still introduced when
applying manual thresholds. Histologic correlation, while
desirable, was not available in this clinical cohort. How-
ever, a recently reported histologic study by Moravsky
et al. provides complementary findings by comparing
histological findings from septal myectomy samples to re-
gionally matched LGE segmentation. While this study
could not assess total LGE burden (i.e.: limited to the
myomectomy sample itself), the STRM technique was
similarly favoured for accurate estimates of total fibrosis
burden [29]. Specifically, they found a >4SD threshold most
closely approximated percent collagen deposition within
the septal myomectomy sample – a threshold highly con-
sistent with our current findings. Similar to our findings,
they identified that the FWHM technique systematically
under-represented histologically based measurements of
fibrosis.
Finally, the process by which segmentation boundaries
and reference tissues are identified is a dominant harbin-
ger of variability for LGE quantification. The reproduci-
bility reported in this study is based upon rigorous
attention to standard operating procedures established
within a core-laboratory environment and therefore rep-
resents ideal operating conditions. It is strongly advised
that efforts be made to follow an established set of rules
when executing LGE quantification, such as those out-
lined in the methods section of this study.
Conclusions
In this large cohort study, the STRM >3SD LGE segmenta-
tion technique provided greatest accuracy and an acceptable
reproducibility for total LGE burden quantification versus
the reference standard of expert, slice-by-slice adjustmentof a SI threshold to quantitate extent of LGE. In contrast,
FWHM-based segmentation is highly reproducible but pro-
vides a systematic under-representation of total LGE burden
versus expert opinion. Consensus opinion regarding the
preferred LGE segmentation methodology is required to
facilitate the clinical translation of LGE quantification in
the risk stratification of patients with HCM.
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